Oxford Biomedica Plc (OXBL)

367.00p
   
  • Change Today:
      0.13p
  • 52 Week High: 444.50
  • 52 Week Low: 235.50
  • Currency: UK Pounds
  • Volume: 3,147

Fundamentals - based on IFRS

  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Income Statement 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Continuing Operations          
Revenue 128.80 89.54 139.99 142.80 87.73
Operating Profit/(Loss) (39.38) (184.17) (30.22) 20.77 (5.69)
Profit Before Tax (47.26) (188.53) (45.98) 19.88 (6.57)
Profit After Tax (48.61) (184.16) (45.16) 19.01 (6.24)
           
Earnings per Share - Basic (41.75p) (163.11p) (41.29p) 22.77p (7.81p)
Earnings per Share - Adjusted (41.75p) (163.11p) (41.29p) 22.77p (7.81p)
           
Dividend per Share n/a n/a n/a n/a n/a
  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Balance Sheet 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Assets          
Non-Current Assets          
Property, Plant & Equipment 64.30 75.69 133.78 69.73 72.30
Intangible Assets 29.22 30.98 105.89 0.05 0.07
Other Non-Current Assets 4.93 4.34 5.01 3.61 3.61
  98.45 111.01 244.68 73.39 75.98
Current Assets          
Inventories 13.57 12.87 12.62 9.52 6.91
Cash at Bank & in Hand 60.65 103.72 141.29 108.94 46.74
Other Current Assets n/a n/a n/a 0.63 0.37
  133.19 141.33 215.50 163.84 107.95
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 231.64 252.34 460.18 237.23 183.93
Current Liabilities          
Borrowings 4.42 3.65 3.30 0.85 4.47
Other Current Liabilities 53.90 40.66 56.37 32.45 47.98
           
Current Liabilities 58.32 44.31 59.66 33.31 52.45
           
Net Current Assets cn/a cn/a cn/a cn/a cn/a
           
Borrowings 104.34 107.80 110.99 8.49 9.37
Other Non-Current Liabilities 0.05 13.84 39.33 1.85 3.52
Non-Current Liabilities 112.84 130.19 164.32 16.58 18.73
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 171.16 174.51 223.99 49.89 71.18
           
Net Assets 60.49 77.83 236.19 187.34 112.75
           
Shareholders Funds 57.05 74.01 204.65 187.34 112.75
           
Minority Interests/Other Equity 3.44 3.83 31.54 n/a n/a
Total Equity 60.49 77.83 236.19 187.34 112.75
Cash Flow 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Net Cash Flow From Operating Activities (50.67) (28.52) (12.61) 25.45 3.12
Net Cash Flow from Investing Activities 5.63 2.81 (56.46) (9.46) (10.80)
Net Cash Flow from Financing Activities 2.91 (12.70) 98.62 46.21 38.19
Net Increase/Decrease In Cash (42.13) (38.41) 29.55 62.20 30.50
Ratios - based on IFRS 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Continuing Operations          
PE Ratio - Adjusted n/a n/a n/a 53.9 n/a
PEG - Adjusted n/a n/a n/a n/a n/a
Earnings per Share Growth - Adjusted n/a n/a n/a n/a n/a
Dividend Cover n/a n/a n/a n/a n/a
Revenue per Share n/a n/a n/a n/a 109.74p
Pre-Tax Profit per Share n/a n/a n/a n/a (8.22p)
Operating Margin (30.57%) (205.69%) (21.59%) 14.54% (6.49%)
Return on Capital Employed n/a n/a n/a 10.24% n/a
           
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0%
Dividend per Share Growth n/a n/a n/a n/a n/a
Operating Cash Flow per Share n/a n/a n/a n/a 3.90p
Cash Incr/Decr per Share n/a n/a n/a n/a 38.15p
Net Asset Value per Share (exc. Intangibles) n/a n/a n/a n/a 140.94p
Net Gearing 84.34% 10.46% -13.20% -53.17% -29.18%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

Note 2: Forecast figures based on normalised accounts.

 

Top of Page